清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

S1791 Comparing Outcomes and Associations in HCC-Related Portal Vein Thrombosis With Non-Malignant Portal Vein Thrombosis: A 5-Year National Inpatient Sample Study

作者
Medha Rajamanuri,Sai Shanmukha Sreeram Pannala,Mark Ayoub,Vinay Jahagirdar,Sophia Haroon Dar,Muhammad H. N. Chaudhary,Vishwajit Kode,Nadeem Anwar
出处
期刊:The American Journal of Gastroenterology [Lippincott Williams & Wilkins]
卷期号:119 (10S): S1295-S1296
标识
DOI:10.14309/01.ajg.0001036532.90465.d8
摘要

Introduction: Portal vein thrombosis (PVT) is a blockage of the portal vein caused by a blood clot, often due to cirrhosis, malignancy, or other hypercoagulable states involving Virchow's triad: sluggish blood flow, endothelial damage, and increased blood coagulation. In hepatocellular carcinoma (HCC) patients, PVT can also result from direct invasion of the portal vein. This study compares benign PVT and malignant PVT (secondary to HCC) by examining baseline characteristics, risk factors, comorbidities, and in-hospital outcomes. Methods: Using the National Inpatient Sample (NIS) database from 2016 to 2020, we identified hospitalizations with PVT associated with HCC and non-malignant PVT using ICD-10 codes. This retrospective cohort study excluded pregnant women and patients on chronic anticoagulation. Multivariate logistic regression compared outcomes adjusted for baseline characteristics and comorbidities. Results: The study investigated 138,790 PVT cases: 115,185 benign and 23,605 malignant. Benign PVT patients had a mean age of 52.75 years, compared to 63.5 years in malignant cases (P < 0.0001). HCC-PVT was more common in males (75% vs 53%, P < 0.0001), with significant racial differences (P < 0.001). Benign PVT had higher rates of pancreatitis, hyperlipidemia, and obesity (P = 0.01), while malignant PVT was associated with higher rates of chronic kidney disease, type 2 diabetes, chronic viral hepatitis, and cirrhosis (all P < 0.05). Non-malignant PVT had significantly higher incidences of adverse outcomes, including major adverse cardiovascular events, acute mesenteric ischemia, cholestasis, sepsis, cerebrovascular events, and variceal and non-variceal upper GI bleeds (all P < 0.05) (Table 1, Figure 1). Conclusion: Significant differences exist between non-malignant and HCC-associated PVT in demographics, comorbidities, and in-hospital outcomes. HCC-associated PVT patients have higher rates of ascites, while non-malignant PVT patients face higher rates of complications such as upper GI bleeds, acute mesenteric ischemia, and major cardiovascular and cerebrovascular events. These findings underscore the impact of non-malignant PVT on patient outcomes. Further research is needed to develop tailored management strategies to optimize outcomes for these patients.Figure 1.: Baseline characteristics and comorbidities of HCC vs non-malignant PVT. Table 1. - Comparing in-patient outcomes in patients with non-malignant portal vein thrombosis versus hepatocellular carcinoma associated portal vein thrombosis Outcome Benign PVT HCC and PVT Adjusted Odds Ratio P-Value Died during hospitalization 7.40% (8524) 12.84% (3034) 0.9034981 0.134 Ascites 23.72% (27343) 40.78% (9617) 0.8095664 0 Hepatic Encephalopathy 0.59% (679) 0.74% (174) 0.589 0 Cholestasis 4.14% (4776) 5.64% (1332) 0.734 0.039 VUGIB 1.44% (1659) 2.12% (500) 1.475602 0.013 NVUGIB 1.81% (2083) 1.29% (304) 2.473463 0 Acute mesenteric ischemia 2.51% (2892) 0.66% (156) 2.075 0 MACE 0.96% (1106) 0.51% (121) 4.773 0 Cerebrovascular events 0.76% (878) 0.42% (99) 4.914 0 Sepsis 18.52% (21352) 12.40% (2929) 1.770424 0

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
3秒前
清爽的天川完成签到,获得积分10
4秒前
Hhhhh完成签到 ,获得积分10
11秒前
lianxin完成签到 ,获得积分10
16秒前
76完成签到 ,获得积分10
16秒前
淘宝完成签到,获得积分10
21秒前
俏皮的以莲完成签到,获得积分10
29秒前
31秒前
Zhangxinyi完成签到 ,获得积分10
34秒前
萧水白完成签到,获得积分10
36秒前
Puan发布了新的文献求助10
37秒前
虚心问旋完成签到,获得积分10
41秒前
SAY完成签到 ,获得积分10
48秒前
49秒前
57秒前
11发布了新的文献求助10
1分钟前
清爽的人英完成签到,获得积分10
1分钟前
阳光绿柳发布了新的文献求助10
1分钟前
快乐唇彩完成签到,获得积分10
1分钟前
爆米花的应助被11采纳,获得10
1分钟前
sissiarno的应助被科研通管家采纳,获得30
1分钟前
sissiarno的应助被科研通管家采纳,获得40
1分钟前
JamesPei的应助被xiaoju采纳,获得10
1分钟前
1437594843完成签到 ,获得积分10
1分钟前
眯眯眼的安雁完成签到 ,获得积分10
1分钟前
1分钟前
淡然的半烟完成签到,获得积分10
1分钟前
wang完成签到,获得积分10
1分钟前
xiaoju发布了新的文献求助10
1分钟前
1分钟前
GingerF的应助被Noufil采纳,获得250
1分钟前
阳光绿柳发布了新的文献求助10
1分钟前
GingerF的应助被Noufil采纳,获得110
1分钟前
飞快的乘风完成签到,获得积分10
1分钟前
Nole的应助被李明采纳,获得20
1分钟前
自觉的猕猴桃完成签到,获得积分10
2分钟前
李明完成签到,获得积分10
2分钟前
keyanxiaobai完成签到 ,获得积分10
2分钟前
明理冰海完成签到,获得积分10
2分钟前
xuexixiaojin完成签到 ,获得积分10
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Hidden Empire of Finance: How Wall Street Profits from Our Cities and Fuels Global Inequality 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8166463
求助须知:如何正确求助?哪些是违规求助? 9559494
关于积分的说明 21750516
捐赠科研通 7757246
什么是DOI,文献DOI怎么找? 3429141
关于科研通互助平台的介绍 2553507
邀请新用户注册赠送积分活动 2473845